For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Kayseri 38039

0 studies enrolling now · 5 studies all time

What they study most

Diabetes Mellitus, Type 2, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Non-Small Cell Lung Cancer, Small Cell Lung Cancer

Studies at this site

• A Study of Ramucirumab (LY3009806) in Combination With Paclitaxel in Participants With Gastric Cancer — Completed
• A Study of Prexasertib (LY2606368) in Participants With Extensive Stage Disease Small Cell Lung Cancer — Completed
• A Study of Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based Chemotherapy — Completed
• A Study in Participants With Type 2 Diabetes Mellitus — Completed
• A Study in Patients With Type 2 Diabetes Mellitus — Completed